The nitinol medical devices market is estimated to be valued at US$ 44305.49 Mn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Nitinol medical devices are primarily used in minimally invasive surgeries and procedures. Products like guidewires, embolization coils, filters stents, etc are widely used in cardiovascular surgeries, urology, neurology and other specialties. Features like shape memory effect, superelasticity and corrosion resistance make nitinol attractive for manufacturing medical devices. The increasing demand for minimally invasive techniques is driving innovations in nitinol based devices.
Market Dynamics:
One of the key drivers contributing to growth of nitinol medical devices market is rising prevalence of chronic diseases like cardiovascular diseases, cancer and neurological disorders. These conditions often require minimally invasive procedures in which nitinol based stents, filters and other implants are used. According to World Health Organization, cardiovascular diseases are the leading cause of death globally, taking an estimated 17.9 million lives each year. Additionally, increasing geriatric population also elevates the risk of chronic ailments. For example, as per United Nations estimates, number of people aged 65 years or over is projected to grow to nearly 1.5 billion in 2050 from 703 million in 2019. The other driver is technological advancements in materials used for manufacturing which is leading to development of novel nitinol based medical devices with improved properties. This is further expanding applications of nitinol and propelling market growth over the forecast period.
SWOT Analysis
Strength: Nitinol medical devices have high biocompatibility and corrosion resistance which makes them suitable for long term implants. Their shape memory properties allow minimally invasive procedures. They can regain their pre-defined shape on applying heat helping in better treatment outcomes.
Weakness: High material and manufacturing costs of Nitinol increases the overall cost of these medical devices. Challenges in controlling the transition temperature precisely can affect shape memory behavior.
Opportunity: Rising geriatric population suffering from cardiovascular and orthopedic conditions will drive the demand. Growing preference for minimally invasive surgeries increases the scope of nitinol usage.
Threats: Stringent regulatory approval process delays product launch. Presence of alternatives like polymers and stainless steel restrict the market growth to some extent.
Key Takeaways
The global Nitinol Medical Devices Market Growth is expected to witness high growth, exhibiting CAGR of 10% over the forecast period, due to increasing prevalence of cardiovascular, neurological and orthopedic disorders. The market size is projected to reach US$ 96403.46 Mn by 2030 from US$ 44305.49 Mn in 2023.
Regional analysis: North America dominates the global nitinol medical devices market owing to growing healthcare expenditure and faster adoption of advanced medical technologies. Asia Pacific exhibits the fastest growth due to rising medical tourism, large patient pool and improving healthcare infrastructure.
Key players operating in the Nitinol Medical Devices market are Zimmer Biomet, Merck KgaA, EndoSmart GmbH, Cook Medical, Boston Scientific Inc., B. Braun Melsungen AG, Arthrex Inc., W.L. Gore and Associates Inc., Becton, Dickinson & Company, and Terumo Interventional Systems (Terumo Corporation), among others. Key players are focusing on new product launches, partnerships and geographical expansion strategies to gain market share.
Read More,
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian